To identify the MPE effectors and transcriptional signatures of IL-1β/KRAS/IKKα-addicted tumor cells, we subjected KRAS-silenced, IKKα-silenced, and IL-1β-challenged LLC and MC38 cells to microarray analyses, seeking for transcripts altered heterodirectionally by silencing/challenge. The gene discussed is KRAS; the disease is neoplasm.